FDA Inspection 1099590 — Mylan Pharmaceuticals Inc

Mylan Pharmaceuticals Inc — FEI 1110315

The FDA completed an inspection of Mylan Pharmaceuticals Inc on August 15, 2019 in Morgantown, WV. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). 1 citation was issued during this inspection. Product area: Devices.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 15, 2019
Fiscal Year
2019
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
Morgantown, WV (United States)

Citations

IDCFRDescription
316821 CFR 820.198(a)Complaints